Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Yoneda

Showing results (1-10 of 454) with videos related to

Pageof 46
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 29, 2011
Efficacy of pitavastatin for the treatment of non-alcoholic steatohepatitis patients with dyslipidemiaMasato Yoneda
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 24, 2013
Utility of controlled attenuation parameter measurement for assessing liver steatosis in Japanese patients with chronic liver diseasesMasato Yoneda
Nutrients|December 9, 2023
Interactions between Multiple Organs and Nutritional Metabolism in the Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver DiseaseMasato Yoneda, Atsushi Nakajima
Hepatology (Baltimore, Md.)|May 22, 2023
The role of MRI technology in liver evaluation for NAFLD patients: Advancements and opportunitiesMasato Yoneda, Atsushi Nakajima
Diabetology International|January 4, 2019
Baseline low-density lipoprotein cholesterol predicts the hemoglobin A1c-lowering effect of dapagliflozin in Japanese patients with type 2 diabetes mellitusTomoyuki Iwasaki, Masato Yoneda
The American Journal of Gastroenterology|June 26, 2018
Non-Invasive Diagnosis of Nonalcoholic Fatty Liver DiseaseMasato Yoneda, Kento Imajo, Atsushi Nakajima
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|February 28, 2006
[Non-alcoholic steatohepatitis (NASH). 5. Diagnostic approach. 3) Pathological diagnosis]Shiro Maeyama, Masato Yoneda, Jun Nakajima
Hepatitis Monthly|June 6, 2015
Are platelets count useful for detecting the grade of steatosis?Kento Imajo, Masato Yoneda, Atsushi Nakajima
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 9, 2016
[Clinical Importance of Non-alcoholic Fatty Liver Diseases. Topics: V. Extrahepatic manifestations: cerebral and cardiovascular diseases, chronic kidney disease]Kento Imajo, Masato Yoneda, Atsushi Nakajima
Journal of Pharmacological Sciences|February 26, 2011
Novel findings for the development of drug therapy for various liver diseases: prefaceMasato Yoneda, Atsushi Nakajima, Koichiro Wada
Pageof 46

Showing results (1-10 of 454) with videos related to

Sort By:
Pageof 46
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 29, 2011
Efficacy of pitavastatin for the treatment of non-alcoholic steatohepatitis patients with dyslipidemiaMasato Yoneda
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 24, 2013
Utility of controlled attenuation parameter measurement for assessing liver steatosis in Japanese patients with chronic liver diseasesMasato Yoneda
Nutrients|December 9, 2023
Interactions between Multiple Organs and Nutritional Metabolism in the Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver DiseaseMasato Yoneda, Atsushi Nakajima
Hepatology (Baltimore, Md.)|May 22, 2023
The role of MRI technology in liver evaluation for NAFLD patients: Advancements and opportunitiesMasato Yoneda, Atsushi Nakajima
Diabetology International|January 4, 2019
Baseline low-density lipoprotein cholesterol predicts the hemoglobin A1c-lowering effect of dapagliflozin in Japanese patients with type 2 diabetes mellitusTomoyuki Iwasaki, Masato Yoneda
The American Journal of Gastroenterology|June 26, 2018
Non-Invasive Diagnosis of Nonalcoholic Fatty Liver DiseaseMasato Yoneda, Kento Imajo, Atsushi Nakajima
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|February 28, 2006
[Non-alcoholic steatohepatitis (NASH). 5. Diagnostic approach. 3) Pathological diagnosis]Shiro Maeyama, Masato Yoneda, Jun Nakajima
Hepatitis Monthly|June 6, 2015
Are platelets count useful for detecting the grade of steatosis?Kento Imajo, Masato Yoneda, Atsushi Nakajima
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 9, 2016
[Clinical Importance of Non-alcoholic Fatty Liver Diseases. Topics: V. Extrahepatic manifestations: cerebral and cardiovascular diseases, chronic kidney disease]Kento Imajo, Masato Yoneda, Atsushi Nakajima
Journal of Pharmacological Sciences|February 26, 2011
Novel findings for the development of drug therapy for various liver diseases: prefaceMasato Yoneda, Atsushi Nakajima, Koichiro Wada
Pageof 46